- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.12 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 8 residues within 4Å:- Chain A: C.16, A.338, E.339, G.340, D.341, C.342, Y.343, R.344
Ligand excluded by PLIPEDO.3: 9 residues within 4Å:- Chain A: E.299, L.301, G.317, Q.318, T.319, Q.380
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.28, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.28, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.28
Ligand excluded by PLIPEDO.4: 6 residues within 4Å:- Chain A: T.319, L.322, Q.380, W.381, N.382
- Chain D: P.122
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: D.75, R.76, W.103, S.104, I.147, R.149, E.152
- Ligands: EDO.6
Ligand excluded by PLIPEDO.6: 8 residues within 4Å:- Chain A: R.149, A.171, E.201, E.202, R.217, N.219, Y.329
- Ligands: EDO.5
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain B: C.16, A.338, E.339, G.340, D.341, C.342, Y.343, R.344
Ligand excluded by PLIPEDO.12: 9 residues within 4Å:- Chain B: E.299, L.301, G.317, Q.318, T.319, Q.380
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.19, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.19, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.19
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain B: T.319, L.322, Q.380, W.381, N.382
- Chain C: P.122
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain B: D.75, R.76, W.103, S.104, I.147, R.149, E.152
- Ligands: EDO.15
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain B: R.149, A.171, E.201, E.202, R.217, N.219, Y.329
- Ligands: EDO.14
Ligand excluded by PLIPEDO.20: 8 residues within 4Å:- Chain C: C.16, A.338, E.339, G.340, D.341, C.342, Y.343, R.344
Ligand excluded by PLIPEDO.21: 9 residues within 4Å:- Chain C: E.299, L.301, G.317, Q.318, T.319, Q.380
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.1
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: P.122
- Chain C: T.319, L.322, Q.380, W.381, N.382
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain C: D.75, R.76, W.103, S.104, I.147, R.149, E.152
- Ligands: EDO.24
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain C: R.149, A.171, E.201, E.202, R.217, N.219, Y.329
- Ligands: EDO.23
Ligand excluded by PLIPEDO.29: 8 residues within 4Å:- Chain D: C.16, A.338, E.339, G.340, D.341, C.342, Y.343, R.344
Ligand excluded by PLIPEDO.30: 9 residues within 4Å:- Chain D: E.299, L.301, G.317, Q.318, T.319, Q.380
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.10, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.10, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN.10
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: P.122
- Chain D: T.319, L.322, Q.380, W.381, N.382
Ligand excluded by PLIPEDO.32: 8 residues within 4Å:- Chain D: D.75, R.76, W.103, S.104, I.147, R.149, E.152
- Ligands: EDO.33
Ligand excluded by PLIPEDO.33: 8 residues within 4Å:- Chain D: R.149, A.171, E.201, E.202, R.217, N.219, Y.329
- Ligands: EDO.32
Ligand excluded by PLIP- 4 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
MES.7: 10 residues within 4Å:- Chain A: L.11, T.12, H.158, E.208, R.209, T.210, G.211, D.231, P.232, V.233
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.209
- Water bridges: A:T.12
MES.16: 10 residues within 4Å:- Chain B: L.11, T.12, H.158, E.208, R.209, T.210, G.211, D.231, P.232, V.233
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.209
- Water bridges: B:T.12
MES.25: 10 residues within 4Å:- Chain C: L.11, T.12, H.158, E.208, R.209, T.210, G.211, D.231, P.232, V.233
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.209
- Water bridges: C:T.12
MES.34: 10 residues within 4Å:- Chain D: L.11, T.12, H.158, E.208, R.209, T.210, G.211, D.231, P.232, V.233
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:R.209
- Water bridges: D:T.12
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 2 residues within 4Å:- Chain A: N.70, W.362
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:N.70
- Water bridges: A:W.362, A:W.362, C:Y.391
NAG.17: 2 residues within 4Å:- Chain B: N.70, W.362
4 PLIP interactions:1 interactions with chain D, 3 interactions with chain B- Water bridges: D:Y.391, B:W.362, B:W.362
- Hydrogen bonds: B:N.70
NAG.26: 2 residues within 4Å:- Chain C: N.70, W.362
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain C- Water bridges: B:Y.391, C:W.362, C:W.362
- Hydrogen bonds: C:N.70
NAG.35: 2 residues within 4Å:- Chain D: N.70, W.362
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:N.70
- Water bridges: D:W.362, D:W.362, A:Y.391
- 4 x CA: CALCIUM ION(Non-covalent)
CA.9: 7 residues within 4Å:- Chain A: D.218, N.219, G.222, S.223, D.249, N.271, G.272
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.218, A:G.222, A:D.249, A:N.271, H2O.7, H2O.13
CA.18: 7 residues within 4Å:- Chain B: D.218, N.219, G.222, S.223, D.249, N.271, G.272
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.218, B:G.222, B:D.249, B:N.271, H2O.29, H2O.35
CA.27: 7 residues within 4Å:- Chain C: D.218, N.219, G.222, S.223, D.249, N.271, G.272
6 PLIP interactions:4 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.218, C:G.222, C:D.249, C:N.271, H2O.52, H2O.58
CA.36: 7 residues within 4Å:- Chain D: D.218, N.219, G.222, S.223, D.249, N.271, G.272
6 PLIP interactions:4 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.218, D:G.222, D:D.249, D:N.271, H2O.75, H2O.81
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Cell Host Microbe (2019)
- Release Date
- 2019-12-04
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.12 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Cell Host Microbe (2019)
- Release Date
- 2019-12-04
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A